Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lomakin

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Acta Naturae|May 8, 2023
B Cell Profiling in Patients with Pemphigus VulgarisV A Abrikosova, Y A Mokrushina, L A Ovchinnikova, et al.
Blood|January 29, 2021
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosisArtem Kalinichenko, Giovanna Perinetti Casoni, Loïc Dupré, et al.
Pharmaceutics|January 23, 2024
Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α DerivativeMaria B Sokol, Veronika A Beganovskaya, Mariia R Mollaeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Communications Biology|July 10, 2024
Two-dimensional high-throughput on-cell screening of immunoglobulins against broad antigen repertoiresYakov A Lomakin, Leyla A Ovchinnikova, Stanislav S Terekhov, et al.
Science (New York, N.Y.)|October 16, 2020
The nucleus acts as a ruler tailoring cell responses to spatial constraintsA J Lomakin, C J Cattin, D Cuvelier, et al.
Science Immunology|July 11, 2020
The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunityElisabeth Salzer, Samaneh Zoghi, Máté G Kiss, et al.
Cancer Research|June 25, 2017
<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian CarcinomasDariush Etemadmoghadam, Walid J Azar, Ying Lei, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Acta Naturae|May 8, 2023
B Cell Profiling in Patients with Pemphigus VulgarisV A Abrikosova, Y A Mokrushina, L A Ovchinnikova, et al.
Blood|January 29, 2021
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosisArtem Kalinichenko, Giovanna Perinetti Casoni, Loïc Dupré, et al.
Pharmaceutics|January 23, 2024
Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α DerivativeMaria B Sokol, Veronika A Beganovskaya, Mariia R Mollaeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Communications Biology|July 10, 2024
Two-dimensional high-throughput on-cell screening of immunoglobulins against broad antigen repertoiresYakov A Lomakin, Leyla A Ovchinnikova, Stanislav S Terekhov, et al.
Science (New York, N.Y.)|October 16, 2020
The nucleus acts as a ruler tailoring cell responses to spatial constraintsA J Lomakin, C J Cattin, D Cuvelier, et al.
Science Immunology|July 11, 2020
The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunityElisabeth Salzer, Samaneh Zoghi, Máté G Kiss, et al.
Cancer Research|June 25, 2017
<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian CarcinomasDariush Etemadmoghadam, Walid J Azar, Ying Lei, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Pageof 36